Correspondence and General Collaboration Papers

Correspondence and papers relating to the research collaboration between The Charing Cross Sunley Research Centre, The Kennedy Institute and Centocor Biotech.

Includes initial proposals from Marc Feldmann and Ravinder Maini to Centocor, early cA2 trials arrangement and strategy, early cA2 trial patient data and results, funding/costing information, patent applications and summaries, correspondence relating to competing pharmaceutical company research, meeting administration and agendas, draft manuscripts and related correspondence, collaboration reports, grants correspondence, wider research collaborations, costings, adverse event correspondence, cA2 licensing papers, Centocor annual reports, researching and licensing agreements, FDA approvals, royalties and invention negotiations.

Correspondence contributors largely include Marc Feldmann, Ravinder Maini (Charing Cross Sunley Research Centre/ Kennedy Institute), Jim Woody, Peter Daddona, John Ghrayeb, Hubert Schoemaker and Hanny Bijl (Centocor) and Nikolai Voitenok .